Summary
| Direction in PACVS | ↑ Elevated — higher than in the comparison group |
|---|---|
| Category | Autoimmune |
| Also described as | RAS-related GPCR |
| Compared against | HC (healthy controls) |
| Associated symptoms | Widespread burning sensation |
| Test type | Blood test (serum / plasma / whole blood) |
| Source | Mantovani et al. 2024 — doi:10.3390/biomedicines12122852 |
| Condition atlas | PACVS Biomarker Atlas |
Related Autoimmune markers in PACVS
- Anti-AT1R (angiotensin II type 1 receptor) ↑
- Anti-STAB1 autoantibodies ↑
- Anti-ACE2 autoantibodies ↑
- Anti-ADRA2A (α2B adrenergic receptor) ↓
- Anti-CHRM3 (muscarinic M3) ↕
- Anti-idiotype antibodies (ACE2 ↔ Anti-S) ↕
- Anti-GPCR autoantibodies (panel) ↑
Full list: PACVS Biomarker Atlas.
Frequently asked questions
Is Anti-MAS1 receptor autoantibodies high or low in PACVS?
Elevated. Studies summarised in the OSMF atlas report higher Anti-MAS1 receptor autoantibodies in PACVS than in healthy controls. Source: Mantovani et al. 2024.
What symptoms is Anti-MAS1 receptor autoantibodies associated with in PACVS?
The cited literature associates this marker with Widespread burning sensation. These are population-level associations and do not mean the marker causes the symptoms.
Which test measures Anti-MAS1 receptor autoantibodies?
It is measured as a blood test (serum / plasma / whole blood). Many of the cited studies used research-grade assays, so clinical availability may vary.
Is one abnormal Anti-MAS1 receptor autoantibodies result diagnostic of PACVS?
No. No single biomarker is diagnostic of PACVS. Anti-MAS1 receptor autoantibodies findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.
Cite this page
Subscribe on Substack
Last reviewed: 2026-06-30 · Page generated from pacvs.json · Browse: PACVS atlas · Biomarker Index · All marker pages
Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.